course
The Journey of Medicine: From lab to patient in the EU
The Journey of Medicine: From lab to patient in the EU
The Journey of Medicine: From lab to patient in the EU

About the Course

Introduction to this course: 

This course explores the journey of a new medicinal product from the lab to patient authorization in the EU. Learn the six-step process, submission requirements, and marketing authorization essentials.


Who should attend: 

Pharmaceutical professionals, regulatory affairs specialists, biotech researchers, and anyone involved in drug development and approval processes.


Learning Outcomes: 

By the end of this lesson, you will be able to:

  • Identify the six steps of the EU drug authorization process.

  • Implement good clinical practices in clinical trials.


What will I gain: 

Participants will gain a thorough understanding of the EU's centralized drug approval process and the ability to navigate regulatory requirements effectively.


Prerequisites: 

Basic knowledge of pharmaceutical development and regulatory frameworks is recommended.


Additional information: 


Course duration: 00:16:29

Course code/version (effective date): L-153/v1.0 (2/04/2024)

Course Categories

GxP Regulations
Course Progress
Not started
Enroll
Course Outline
  1. The journey of medicine: from lab to patient in the EU
    1. Lesson 1: The journey: from lab to patient (part 1): Steps 1 and 2
    2. Lesson 2: The journey: from lab to patient (part 2): Steps 2 and 3
  2. Additional resources
    1. Mind map: The clinical trials journey
  3. Survey
    1. Course survey
course
The Journey of Medicine: From lab to patient in the EU
The Journey of Medicine: From lab to patient in the EU
Course Progress
Not started
Enroll

About the Course

Introduction to this course: 

This course explores the journey of a new medicinal product from the lab to patient authorization in the EU. Learn the six-step process, submission requirements, and marketing authorization essentials.


Who should attend: 

Pharmaceutical professionals, regulatory affairs specialists, biotech researchers, and anyone involved in drug development and approval processes.


Learning Outcomes: 

By the end of this lesson, you will be able to:

  • Identify the six steps of the EU drug authorization process.

  • Implement good clinical practices in clinical trials.


What will I gain: 

Participants will gain a thorough understanding of the EU's centralized drug approval process and the ability to navigate regulatory requirements effectively.


Prerequisites: 

Basic knowledge of pharmaceutical development and regulatory frameworks is recommended.


Additional information: 


Course duration: 00:16:29

Course code/version (effective date): L-153/v1.0 (2/04/2024)

Course Outline
  1. The journey of medicine: from lab to patient in the EU
    1. Lesson 1: The journey: from lab to patient (part 1): Steps 1 and 2
    2. Lesson 2: The journey: from lab to patient (part 2): Steps 2 and 3
  2. Additional resources
    1. Mind map: The clinical trials journey
  3. Survey
    1. Course survey

Course Categories

GxP Regulations
Northpass logo Powered by Northpass